Cardiac Resynchronization Therapy as a Therapeutic Option in Patients With Moderate-Severe Functional Mitral Regurgitation and High Operative Risk
- 23 August 2011
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 124 (8), 912-919
- https://doi.org/10.1161/circulationaha.110.009803
Abstract
Functional mitral regurgitation (MR) is a common finding in heart failure patients with dilated cardiomyopathy and has important prognostic implications. However, the increased operative risk of these patients may result in low referral or high denial rate for mitral valve surgery. Cardiac resynchronization therapy (CRT) has been shown to have a favorable effect on MR. Aims of this study were to (1) evaluate CRT as a therapeutic option in heart failure patients with functional MR and high operative risk and (2) investigate the effect of MR improvement after CRT on prognosis. A total of 98 consecutive patients with moderate-severe functional MR and high operative risk underwent CRT according to current guidelines. Echocardiography was performed at baseline and 6-month follow-up; severity of MR was graded according to a multiparametric approach. Significant improvement of MR was defined as a reduction ≥1 grade. All-cause mortality was assessed during follow-up (median 32 [range 6.0 to 116] months). Thirteen patients (13%) died before 6-months follow-up. In the remaining 85 patients, significant reduction in MR was observed in all evaluated parameters. In particular, 42 patients (49%) improved ≥1 grade of MR and were considered MR improvers. Survival was superior in MR improvers compared to MR nonimprovers (log rank P P =0.043). Cardiac resynchronization therapy is a potential therapeutic option in heart failure patients with moderate-severe functional MR and high risk for surgery. Improvement in MR results in superior survival after CRT.Keywords
This publication has 33 references indexed in Scilit:
- Mitral Valve Surgery for Functional Mitral Regurgitation in Patients with Chronic Heart Failure – Update of the ResultsThe Thoracic and Cardiovascular Surgeon, 2010
- Mechanism of Decrease in Mitral Regurgitation After Cardiac Resynchronization TherapyCirculation: Cardiovascular Imaging, 2009
- Long-Term Effect of Cardiac Resynchronization Therapy on Functional Mitral Valve RegurgitationThe American Journal of Cardiology, 2009
- Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patientsEuropean Heart Journal, 2006
- Clinical Versus Echocardiographic Parameters to Assess Response to Cardiac Resynchronization TherapyThe American Journal of Cardiology, 2005
- Patient Selection for Cardiac Resynchronization TherapyCirculation, 2005
- Effect of cardiac resynchronization therapy on functional mitral regurgitation in heart failureThe American Journal of Cardiology, 2004
- Early improvement in congestive heart failure after correction of secondary mitral regurgitation in end-stage cardiomyopathyAmerican Heart Journal, 1995
- Validity of the minnesota living with heart failure questionnaire as a measure of therapeutic response to enalapril or placeboThe American Journal of Cardiology, 1993
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976